Sortis Pharma
Hyderabad, India· Est.
A Hyderabad‑based CDMO delivering integrated drug development services from molecule to market.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A Hyderabad‑based CDMO delivering integrated drug development services from molecule to market.
OralInjectableTopical
Technology Platform
Integrated pharmaceutical R&D services covering pre‑formulation, formulation, analytical development, stability testing, and technology transfer under ICH/WHO/cGMP standards.
Opportunities
Rising demand for outsourced drug development services and potential expansion into biologics and advanced delivery technologies.
Risk Factors
Intense competition from larger Indian CDMOs and the need for continuous capability upgrades to meet evolving regulatory and therapeutic complexity.
Competitive Landscape
Competes with established Indian CDMOs such as Jubilant, Piramal, and Syngene, differentiating through integrated end‑to‑end services and strict regulatory compliance.